Skip to Content Facebook Feature Image

It’s a Three-peat: TT Capital Partners Named to Inc.’s 2024 List of Founder-Friendly Investors for the Third Straight Year

News

It’s a Three-peat: TT Capital Partners Named to Inc.’s 2024 List of Founder-Friendly Investors for the Third Straight Year
News

News

It’s a Three-peat: TT Capital Partners Named to Inc.’s 2024 List of Founder-Friendly Investors for the Third Straight Year

2024-11-01 01:16 Last Updated At:01:20

MINNEAPOLIS--(BUSINESS WIRE)--Oct 31, 2024--

For the third consecutive year, TT Capital Partners (TTCP) has been named to Inc.’s Founder-Friendly Investors list, which recognizes private equity and venture capital firms with a track record of backing founder-led companies. TTCP is one of only 20 healthcare-focused firms included among the 269 companies on the prestigious list. The firm provides capital, expertise, and insight to healthcare technology and services companies.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241029440837/en/

“Being recognized by Inc. as a founder-friendly business for a third straight year is a proud moment for TT Capital Partners and our team of outstanding professionals,” said Dawn Owens, TTCP CEO. “Our passion is healthcare and supporting the companies that work every day to improve the way our U.S. healthcare system operates. Together, we can build great businesses while making a difference.”

One example is Pyx Health, a social health platform that contracts with health plans to improve care access and quality, eliminate barriers to care, and address the complex health and social needs of plan members. Since TTCP’s investment in July 2023, Pyx Health strengthened its product and technology platform, expanded into new healthcare markets, and grew revenue over 35 percent.

"I believe a private equity firm should be more than just a one-time injection of capital; it needs to be a trusted advisor that guides your company to success," said Pyx Health Co-founder and CEO Cindy Jordan. "When Pyx Health was looking for a PE partner, we sought out a firm that had deep healthcare expertise; was aligned with our core values; was genuinely passionate about helping us achieve our mission; and was just plain easy to get along with. We’ve been working with TTCP for more than a year now, and they’ve checked all of those boxes and more.”

Inc.’s Founder-Friendly List celebrates investors that back founder-led businesses and remain actively involved in helping them thrive. To compile the list, Inc. went straight to the source: entrepreneurs who have sold their businesses and shared their experiences partnering with their investors.

Introduced in 2019, the Founder-Friendly Investors list has established itself as one of Inc.’s most resourceful franchises. It serves as a go-to guide for entrepreneurs who want to grow their companies while retaining an ownership stake. To see the complete 2024 list, visit www.inc.com/founder-friendly-investors/.

About TT Capital Partners

TT Capital Partners (TTCP) provides capital, expertise, and insight to healthcare technology and services companies that have the potential to become market leaders. With its exclusive focus on healthcare, extensive industry network, and deep investing and operating experience, TTCP has invested in some of the most high-growth businesses that are innovating and disrupting how healthcare is delivered, managed and consumed. Learn more at www.TTCapitalPartners.com.

About Inc.

Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of our community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating our future. Inc.'s award-winning work achieves a monthly brand footprint of more than 40 million across a variety of channels, including events, digital, print, video, podcasts, newsletters, and social media. Its proprietary Inc. 5000 list, produced every year since its launch as the Inc. 100 in 1982, analyzes company data to rank the fastest-growing privately held businesses in the United States. The recognition that comes with inclusion on this and other prestigious Inc. lists, such as Female Founders and Power Partners, gives the founders of top businesses the opportunity to engage with an exclusive community of their peers, and credibility that helps them drive sales and recruit talent. For more information, visit www.inc.com.

TT Capital Partners Named to Inc.'s Founder-Friendly Investors List for Three Straight Years (Graphic: Business Wire)

TT Capital Partners Named to Inc.'s Founder-Friendly Investors List for Three Straight Years (Graphic: Business Wire)

NEW YORK (AP) — Free agent outfielder Max Kepler was suspended for 80 games on Friday following a positive test for a banned performance-enhancing substance in violation of Major League Baseball's drug program.

Kepler tested positive for Epitrenbolone, a substance that led to a suspension in 2018 for boxer Manuel Charr. The U.S. Anti-Doping Agency announced the following year that a positive test for the substance caused it to disqualify 90-year-old cyclist Carl Grove from a world record he had set at the 2018 Masters Track National Championship.

Epitrenbolone is a metabolite of Trenbolone, which is contained in some products used in body-building stores and has been used in products to promote cattle growth. Kepler is the first player suspended by MLB for the substance since public announcements of the penalty details began in 2005.

There was no immediate comment from the players' association or his agency.

Kepler accepted the suspension without contesting the discipline in a grievance, a person familiar with the process told The Associated Press. The person spoke on condition of anonymity because that detail was not announced.

Kepler, who turns 33 next month, is an 11-year major league veteran who spent last season with the Philadelphia Phillies after playing his first 10 seasons with the Minnesota Twins. He became a free agent after the World Series.

Fourteen players were suspended last year for positive tests, including two under the major league program. Atlanta Braves outfielder Jurickson Profar was banned for 80 games on March 31 and Philadelphia Phillies closer José Alvarado for 80 games on May 25.

Even if Kepler doesn't have a contract by opening day in March, MLB and the union usually allow a suspended free agent to serve his penalty as long as he is attempting to reach a deal with teams. Because of the suspension, he will be ineligible for the 2026 postseason.

Kepler hit .216 with 18 homers and 52 RBIs last year after agreeing to a $10 million, one-year contract. He was slowed in 2024 by left patellar tendinitis and had core surgery after the season to repair a sports hernia.

Kepler grew up in Germany and signed with the Twins at age 16 in 2009. He has a .235 average with 179 homers and 560 RBIs in his big league career.

AP MLB: https://apnews.com/MLB

FILE - Philadelphia Phillies' Max Kepler during the eighth inning of a baseball game, Wednesday, Sept. 10, 2025, in Philadelphia. (AP Photo/Matt Rourke, File)

FILE - Philadelphia Phillies' Max Kepler during the eighth inning of a baseball game, Wednesday, Sept. 10, 2025, in Philadelphia. (AP Photo/Matt Rourke, File)

Recommended Articles